Results of a prospective randomized study of hepatic artery infusion with 5-fluorouracil versus intravenous 5-fluorouracil in patients with hepatic metastases from colorectal cancer: a central oncology group study. Grage TB, Vassilopoulos PP, Shingleton WW, et al. Ambulatory hepatic artery infusion chemotherapy for cancer of the liver. Thirlwell MP, Hollingsworth LM, Herba MJ, Boileau G, Boos G, Macfarlane JK. Hepatic arterial chemotherapy for colorectal cancer metastatic to the liver. Stagg RJ, Lewis BJ, Friedman MA, Ignoffo RJ, Hohn DC. A retrospective study of the natural history of patients with liver metastases from colorectal cancer. Factors influencing survival in patients with untreated hepatic metastases. Jaffe BM, Donegan WL, Watson F, Spratt JS. Treatment of colorectal hepatic metastases. Proceedings of drug delivery systems neurological and oncologic applications. Chronopharmacocinetique du 5 FU en administration continue. Petit E, Milano G, Levi F, Thyss A, Schneider M, Bailleul F. Steady-state nonlinear pharmacokinetics of 5-fluorouracil during hepatic arterial and intravenous infusion in cancer patients. Fluorodeoxyuridine uptake by human colorectal hepatic metastases after hepatic artery infusion. A clinical pharmacologic evaluation of hepatic arterial infusions of 5-fluoro-2′-deoxyuridine and 5-fluorouracil. Proc Am Soc Clin Oncol 1983 2:25(C-98).Įnsminger WD, Rosowsky A, Raso V, et al. Dependence of hepatic arterial fluorouracil pharmacokinetics on dose rate and duration of infusion. Philadelphia: WB Saunders, 1982:77–99.Įnsminger W, Stetson P, Gyves J, et al. Pharmacologic principles of cancer treatment. The distribution of hepatic artery and portal vein blood to ‘small’ and ‘large tumours’. The blood supply of experimental liver metastases. N Engl J Med 1987 316:889–97.Īckermann NB, Lien WM, Kondi ES, Silverman NA. A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high dose interleukin-2 alone. Dordrecht: Martinus Nijhoff Publishers, 1984:249–62. In: Van de Velde CJH, Sugarbaker PH, eds. A possible role in the treatment of hepatic metastases. The systemic chemotherapy of hepatic metastases. Die chirurgische Therapie der Lebermetastasen.
0 kommentar(er)
